Announcement
07 Feb 2023
In February 2023, CFIUS cleared the acquisition of US-based Opiant Pharmaceuticals by UK-based Indivior PLC.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
List of interventions
Implementation date
07 Feb 2023
Revocation date:
No revocation date
Updated: 07 Feb 2023
FDI: Entry and ownership rule
In force
On 7 February 2023, Opiant Pharmaceuticals announced that the Committee on Foreign Investment in the United States (CFIUS) approved the acquisition of Opiant by Indivior PLC.
Opiant announced that the...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.